The Asia-Pacific Digital Pathology Market was worth USD 66.49 million in 2018 and estimated to be growing at a CAGR of 11.13%, to reach USD 112.69 million by 2023. Digital pathology is defined as an image-based information environment for the management, analysis, and the interpretation of the information achieved from a digital slide. In short, the digitalization of conventional pathology lab is referred as digital pathology. This technology has gained momentum in the medical and healthcare industry, owing to the improvements it brings in a number of application such as drug discoveries and their development, multi-functionalities in instruments, diagnostic tests and other research applications.
Increasing no. of cancer cases, growing presence of tele-consultations, high efficacy of digital pathology systems with increased adoption rate and more initiatives undertook by government as well as private companies are helping the cause of the digital pathology market. On the other hand, barriers such as strict regulatory concerns for primary diagnosis, lack of standard guidelines for digital pathology, nonexistence of reimbursement and deficiency in skilled personnel are some of the major factors that are constraining the market in all likelihood. However, mounting requirement for sophisticated healthcare facilities which can be met through establishing digital pathology systems, would offer lucrative opportunities for the service providers in the future if they can overcome threats like high cost of installing new technology or building new infrastructure.
The Asia-Pacific Digital Pathology Market is thoroughly segmented by Type, Product, Application and End user. Further based on type it is segmented into Human Digital Pathology and Animal Digital Pathology. While by Product it is categorized into Scanners, Software, Communication Systems and Storage Systems, based on Application it is segmented into Teleconsultation, Diseases Diagnosis, Drug Discovery and Training & Education categories. Finally, by End User it is segmented into Pharmaceutical Companies, Hospitals and Academic Institutions. While Scanners segment accounts for the largest market share in 2015, software segment is surely catching up to it growing fast paced with the development of technology. On the other hand, based on geography it is segmented and analysed under the regions of India, China, Japan, South Korea and Australia.
Digital pathology industry is consolidating, as players in the industry are entering into partnerships, mergers and acquisitions and well-planned distribution strategies to capitalize on the overall opportunities present in untapped markets. Some of the key players operating in the market include Perkin Elmer, Inc., Definiens AG, Sectra AB, Koninklijke Philips N.V, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd, Hamamatsu Photonics, K.K., Digipath Co., ZEISS, Olympus Corporation, Yokogawa Electronic Corporation and Quorum Technologies Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.1 Human Digital Pathology
5.1.2 Animal Digital Pathology
5.2 By Product
5.2.1 Scanners
5.2.2 Software
5.2.3 Communication Systems
5.2.4 Storage Systems
5.3 By Application
5.3.1 Teleconsultation
5.3.2 Disease Diagnosis
5.3.3 Drug Discovery
5.3.4 Training and Education
5.4 By End User
5.4.1 Pharmaceutical Companies
5.4.2 Hospitals
5.4.3 Academic Institutes
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1. Perkin Elmer, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2. Definiens AG
8.3. Sectra AB
8.4. Koninklijke Philips N.V
8.5. GE Healthcare
8.6. Inspirata Co.
8.7. Ventana Medical Systems, Inc.
8.8. Leica Biosystems
8.9. 3D-Histech Ltd
8.10. Hamamatsu Photonics, K.K.
8.11. Digipath Co.
8.12. ZEISS
8.13. Olympus Corporation
8.14. Yokogawa Electronic Corporation
8.15. Quorum Technologies Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
